Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling
John B. Pawlak, … , Zoltán Jakus, Kathleen M. Caron
John B. Pawlak, … , Zoltán Jakus, Kathleen M. Caron
Published August 15, 2019
Citation Information: J Clin Invest. 2019;129(11):4912-4921. https://doi.org/10.1172/JCI120446.
View: Text | PDF
Research Article Reproductive biology Vascular biology

Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling

  • Text
  • PDF
Abstract

Molecular heterogeneity of endothelial cells underlies their highly specialized functions during changing physiological conditions within diverse vascular beds. For example, placental spiral arteries (SAs) undergo remarkable remodeling to meet the ever-growing demands of the fetus — a process which is deficient in preeclampsia. The extent to which maternal endothelial cells coordinate with immune cells and pregnancy hormones to promote SA remodeling remains largely unknown. Here we found that remodeled SAs expressed the lymphatic markers PROX1, LYVE1, and VEGFR3, mimicking lymphatic identity. Uterine natural killer (uNK) cells, which are required for SA remodeling and secrete VEGFC, were both sufficient and necessary for VEGFR3 activation in vitro and in mice lacking uNK cells, respectively. Using Flt4Chy/+ mice with kinase inactive VEGFR3 and Vegfcfl/fl Vav1-Cre mice, we demonstrated that SA remodeling required VEGFR3 signaling, and that disrupted maternal VEGFR3 signaling contributed to late-gestation fetal growth restriction. Collectively, we identified a novel instance of lymphatic mimicry by which maternal endothelial cells promote SA remodeling, furthering our understanding of the vascular heterogeneity employed for the mitigation of pregnancy complications such as fetal growth restriction and preeclampsia.

Authors

John B. Pawlak, László Bálint, Lillian Lim, Wanshu Ma, Reema B. Davis, Zoltán Benyó, Michael J. Soares, Guillermo Oliver, Mark L. Kahn, Zoltán Jakus, Kathleen M. Caron

×

Figure 3

Loss of VEGFR3 signaling is sufficient to impair SAR.

Options: View larger image (or click on image) Download as PowerPoint
Loss of VEGFR3 signaling is sufficient to impair SAR.
(A and B) The dens...
(A and B) The density of uNK cells in the placental decidua of Flt4Chy/+ mice is similar to WT at E13.5 (per group, n = 6 total placentas from 3 litters with 2 placentas from each litter; unpaired t test). (C) VEGFR3 signaling–deficient Flt4Chy/+ mice retain more SA SMC coverage (blue) compared with WT, even while total expression of VEGFR3 is unchanged. (D) Quantification of endothelial ERK phosphorylation (p-ERK) of WT and Flt4Chy/+ mice at E13.5 (per group, n = 5 total placentas from 3 litters with 1–2 placentas from each litter; 2-way ANOVA with Bonferroni posttest, P = 0.0002). (E) Quantification of the percentage of SA perimeter covered in αSM-actin+ SMCs of WT and Flt4Chy/+ mice at E13.5 (per group, n = 6–9 total placentas from 3 litters with 2–3 placentas from each litter; 2-way ANOVA with Bonferroni posttest, P = 0.0001). (F) H&E staining of SAs in WT and Flt4Chy/+ mice at E11.5 and E13.5. (G and H) Quantification of the luminal area and wall thickness (ratio of vessel wall to lumen area) of SAs in WT and Flt4Chy/+ mice at E11.5 and E13.5 (per group, n = 21–35 total placentas from 3 litters with 4–13 placentas from each litter; 2-way ANOVA with Bonferroni posttest, P < 0.0001 for G and H). (I–K) Flt4Chy/+ mice exhibit fetal growth restriction and increased placental weights at E18.5 (per genotype, n = 33–44 total embryos and placentas from 3 litters with 9–16 embryos from each litter; unpaired t test). All scale bars: 50 μm. In all graphs the red horizontal line represents the mean. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 versus control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts